CHMP review date sets up Pfizer-BioNTech COVID-19 vaccine to earn first EMA approval

The first European approval of a COVID-19 vaccine could come before year-end as EMA sets its deadlines for review of the mRNA vaccines from Moderna and partners Pfizer and BioNTech.

The European Commission has agreed to procure up to 460 million doses of the two vaccines, together comprising more than 20% of its commitments to COVID-19 vaccines...